Pieris Pharmaceuticals Inc (PIRS)
16.98
+0.11
(+0.65%)
USD |
NASDAQ |
Oct 31, 16:00
17.20
+0.22
(+1.30%)
After-Hours: 20:00
Pieris Pharmaceuticals Free Cash Flow: -37.87M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -37.87M |
| March 31, 2024 | -49.82M |
| December 31, 2023 | -53.99M |
| September 30, 2023 | -47.26M |
| June 30, 2023 | -46.28M |
| March 31, 2023 | -48.98M |
| December 31, 2022 | -60.97M |
| September 30, 2022 | -59.34M |
| June 30, 2022 | -65.36M |
| March 31, 2022 | -19.48M |
| December 31, 2021 | -8.609M |
| September 30, 2021 | -11.32M |
| June 30, 2021 | -3.214M |
| March 31, 2021 | -43.73M |
| December 31, 2020 | -48.62M |
| September 30, 2020 | -49.78M |
| June 30, 2020 | -55.93M |
| March 31, 2020 | -56.76M |
| December 31, 2019 | -54.93M |
| September 30, 2019 | -49.40M |
| Date | Value |
|---|---|
| June 30, 2019 | -51.20M |
| March 31, 2019 | -48.92M |
| December 31, 2018 | -2.764M |
| September 30, 2018 | 1.346M |
| June 30, 2018 | 50.94M |
| March 31, 2018 | 53.14M |
| December 31, 2017 | 47.80M |
| September 30, 2017 | 46.35M |
| June 30, 2017 | 7.667M |
| March 31, 2017 | 8.685M |
| December 31, 2016 | -14.95M |
| September 30, 2016 | -10.82M |
| June 30, 2016 | -10.78M |
| March 31, 2016 | -7.734M |
| December 31, 2015 | -13.33M |
| September 30, 2015 | -10.23M |
| June 30, 2015 | -6.698M |
| March 31, 2015 | -3.615M |
| September 30, 2014 | -0.0245M |
| June 30, 2014 | -0.0151M |
Free Cash Flow Range, Past 5 Years
-65.36M
Minimum
Jun 2022
-3.214M
Maximum
Jun 2021
-43.28M
Average
-48.98M
Median
Mar 2023
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals Inc | -8.162M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.48M |
| Cash from Investing (Quarterly) | 2.176M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow Yield | -175.8% |